WO2008053478A3 - Compositions et procédés pour inhiber la réplication et l'activité de l'intégrase du vih-1 - Google Patents

Compositions et procédés pour inhiber la réplication et l'activité de l'intégrase du vih-1 Download PDF

Info

Publication number
WO2008053478A3
WO2008053478A3 PCT/IL2007/001321 IL2007001321W WO2008053478A3 WO 2008053478 A3 WO2008053478 A3 WO 2008053478A3 IL 2007001321 W IL2007001321 W IL 2007001321W WO 2008053478 A3 WO2008053478 A3 WO 2008053478A3
Authority
WO
WIPO (PCT)
Prior art keywords
replication
compositions
methods
inhibiting hiv
integrase activity
Prior art date
Application number
PCT/IL2007/001321
Other languages
English (en)
Other versions
WO2008053478A2 (fr
Inventor
Assaf Friedler
Abraham Loyter
Moshe Kotler
Amnon Hizi
Zvi Hayouka
Joseph Rosenbluh
Aviad Levin
Shoshana Loya
Original Assignee
Yissum Res Dev Co
Univ Ramot
Assaf Friedler
Abraham Loyter
Moshe Kotler
Amnon Hizi
Zvi Hayouka
Joseph Rosenbluh
Aviad Levin
Shoshana Loya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Univ Ramot, Assaf Friedler, Abraham Loyter, Moshe Kotler, Amnon Hizi, Zvi Hayouka, Joseph Rosenbluh, Aviad Levin, Shoshana Loya filed Critical Yissum Res Dev Co
Publication of WO2008053478A2 publication Critical patent/WO2008053478A2/fr
Publication of WO2008053478A3 publication Critical patent/WO2008053478A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des peptides isolés comprenant un fragment d'une protéine LEDGF/p75 et leur utilisation pour traiter l'infection par le VIH-1, inhiber la réplication du VIH-1 et inhiber la liaison de l'ADN et l'activité de traitement de l'extrémité 3' de la protéine intégrase du VIH-1.
PCT/IL2007/001321 2006-10-30 2007-10-30 Compositions et procédés pour inhiber la réplication et l'activité de l'intégrase du vih-1 WO2008053478A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85513006P 2006-10-30 2006-10-30
US60/855,130 2006-10-30

Publications (2)

Publication Number Publication Date
WO2008053478A2 WO2008053478A2 (fr) 2008-05-08
WO2008053478A3 true WO2008053478A3 (fr) 2008-07-03

Family

ID=39137007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2007/001321 WO2008053478A2 (fr) 2006-10-30 2007-10-30 Compositions et procédés pour inhiber la réplication et l'activité de l'intégrase du vih-1

Country Status (1)

Country Link
WO (1) WO2008053478A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
WO2010041241A2 (fr) 2008-10-06 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Peptides dérivés de l'intégrase du vih-1 et compositions
MX2012015097A (es) 2010-07-02 2013-05-28 Gilead Sciences Inc Derivados de acido naft-2-ilacetico para tratar sida.
TWI458711B (zh) 2010-07-02 2014-11-01 Gilead Sciences Inc 治療性化合物
MX2013012266A (es) 2011-04-21 2013-11-22 Gilead Sciences Inc Compuestos de benzotiazol y su uso farmaceutico.
WO2013103738A1 (fr) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Dérivés d'acide naphtalène acétique contre l'infection par le vih
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
SG11201401189WA (en) 2012-04-20 2014-09-26 Gilead Sciences Inc Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
IN2014MN02461A (fr) 2012-05-21 2015-07-10 Univ Colorado Regents

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEREPANOV PETER ET AL.: "Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 47, 19 November 2004 (2004-11-19), pages 48883 - 48892, XP002478701, ISSN: 0021-9258 *
CHEREPANOV PETER ET AL.: "Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 102, no. 48, November 2005 (2005-11-01), pages 17308 - 17313, XP002478700, ISSN: 0027-8424 *
DATABASE PDB [online] 24 September 2005 (2005-09-24), CHEREPANOV P., AMBROSIO A.L., RAHMAN S., ELLENBERGER T., ENGELMAN A.: "Structural basis for the recognition between HIV-1 integrase and LEDGF/p75", XP002478702, retrieved from EBI accession no. PDB:2B4J Database accession no. 2B4J *
DE RIJCK JAN ET AL.: "Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication", 20 September 2006 (2006-09-20), XP002478856, Retrieved from the Internet <URL:http://jvi.asm.org/cgi/reprint/JVI.00801-06v1> [retrieved on 20080430] *
HAYOUKA ZVI ET AL.: "Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium", PNAS, vol. 104, no. 20, 15 May 2007 (2007-05-15), pages 8316 - 8321, XP002478699 *
LATAILLADE MAX ET AL.: "The hunt for HIV-1 integrase inhibitors.", AIDS PATIENT CARE AND STDS JUL 2006, vol. 20, no. 7, July 2006 (2006-07-01), pages 489 - 501, XP009099694, ISSN: 1087-2914 *

Also Published As

Publication number Publication date
WO2008053478A2 (fr) 2008-05-08

Similar Documents

Publication Publication Date Title
WO2008053478A3 (fr) Compositions et procédés pour inhiber la réplication et l&#39;activité de l&#39;intégrase du vih-1
EP2537524A3 (fr) Traitement de maladies induites par les lymphocytes T
WO2007075525A3 (fr) Combinaison de composes organiques
WO2004014312A3 (fr) Compositions a petit mere et leurs procedes d&#39;utilisation
WO2005115398A3 (fr) Inhibiteurs d&#39;integrase de vih
WO2007016538A3 (fr) Preparation et utilisation de derives aminoacides biphenyle pour traiter l&#39;obesite
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
WO2007141796A3 (fr) Utilisations thérapeutiques d&#39;inhibiteurs de rtp801l
WO2005077050A3 (fr) Inhibiteurs de l&#39;integrase du vih
WO2009070294A3 (fr) Inhibition du récepteur de la protéine stimulant les macrophages (ron) et procédés de traitement
WO2005002526A3 (fr) Procedes et compositions pour le traitement d&#39;infections virales
WO2008142303A3 (fr) Utilisation d&#39;un anticorps anti-cxcr4 pour le traitement du cancer
WO2009020559A3 (fr) Agents inhibant les interactions du p-tefb et leurs procédés d&#39;utilisation
WO2007019098A3 (fr) Inhibiteurs de l&#39;integrase du vih
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
WO2006137938A3 (fr) Fragments d&#39;anticorps assurant la protection contre l&#39;infection par des pathogenes, methodes d&#39;utilisation de ces derniers
WO2009047513A3 (fr) Composé, utilisation et procédé
ATE540971T1 (de) Proteinkinase-c-inhibitoren zur prävention von insulinresistenz und typ-2-diabetes
WO2004073615A3 (fr) Composes de deazaflavine et leurs methodes d&#39;utilisation
WO2005070042A8 (fr) Nouveaux composes chimiques
WO2008051448A3 (fr) Procédés et compositions pour l&#39;élimination efficace de la protéine a de préparations de molécules de liaison
WO2006122971A3 (fr) Traitement de maladies a l&#39;aide d&#39;un systeme d&#39;expression regulee, ameliore
WO2008068765A3 (fr) Compositions et procédés pour inhiber la réplication du vih-1 et l&#39;activité de l&#39;intégrase
WO2005081972A3 (fr) Inhibiteurs de phosphatase antitumoraux a base de maleiimide
WO2004037192A3 (fr) Identification et inhibition de cibles anti-mycobacteriennes pour le traitement de maladies infectieuses

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07827295

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07827295

Country of ref document: EP

Kind code of ref document: A2